Get the Stockscreener App
17.83
0.73%
0.13
ADARx Pharmaceuticals, Inc. Common Stock stock is traded at $17.83, with a volume of 285.48K.
It is up +0.73% in the last 24 hours and down -30.22% over the past month.
See More
Previous Close:
$17.70
Open:
$17.72
24h Volume:
285.48K
Relative Volume:
0.44
Market Cap:
$1.90B
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+0.88%
1M Performance:
-30.22%
6M Performance:
-30.22%
1Y Performance:
-30.22%
1-Day Range:
$0.00
$0.00
1-Week Range:
$17.06
$18.82
52-Week Range:
$16.07
$25.55
ADARx Pharmaceuticals, Inc. Common Stock Stock (ADRX) Company Profile
Name
ADARx Pharmaceuticals, Inc. Common Stock
Sector
Industry
Phone
-
Address
-
Compare ADRX vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADRX
ADARx Pharmaceuticals, Inc. Common Stock
|
17.83 | 1.90B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
ADARx Pharmaceuticals, Inc. Common Stock Stock (ADRX) Latest News
Simeon George Discloses Investment at ADARx Pharmaceuticals with 9.3% Stake - TradingView
ADRX News & Events - Intellectia AI
OrbiMed Advisors Discloses Investment at ADARx Pharmaceuticals with 14.0% Stake - TradingView
Upcoming & Recent IPO'sIPOs Calendar - ca.finance.yahoo.com
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering - FinancialContent
Form 4 ADARx Pharmaceuticals For: 30 September By Investing.com - Investing.com South Africa
ADARx Pharmaceuticals Director Reports Preferred Stock Conversions and IPO Share Purchase - Kalkine Media
At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). - Stock Titan
Options on 170,692 shares at $17 each go to ADARx Pharmaceuticals (ADRX) chief scientific officer. - Stock Titan
ADARx Raises $446.3 Million in IPO Priced at $17.00 Per Share - Minichart
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Legal Desire
ADARx Pharmaceuticals Shares Jump On Nasdaq Debut - Yahoo Finance
Another top IPO: Adarx’s $446M to advance clinical siRNA assets - BioWorld News
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Latham & Watkins LLP
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) Income StatementYahoo Finance - Yahoo! Finance Canada
ADARx Pharmaceuticals Prices Upsized $446.3 Million Initial Public Offering - Yahoo Finance
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public - BioSpace
Form S-1 ADARx Pharmaceuticals For: 25 September By Investing.com - Investing.com UK
Adarx Pharmaceuticals IPO opens at $22.10, 30% above pricing - scanx.trade
Articles from ADARx Pharmaceuticals Inc. - FinancialContent
IPO calendar for: - Yahoo Finance Singapore
IPO calendar for: - Yahoo Finance Singapore
ADARx Pharmaceuticals prices $446.3M IPO at $17 per share - Investing.com
ADARx Pharmaceuticals prices upsized IPO at $17 per share - Investing.com
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering - Yahoo Finance
Total common shares outstanding of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - tradingview.com
Diluted net income available to common stockholders of ADARx Pharmaceuticals Inc. – NASDAQ:ADRX - tradingview.com
ADARx Pharmaceuticals (ADRX): ADARx Sets Terms, Targets Up to $372m in IPO, AbbVie Alongside - Smartkarma
ADARx Pharmaceuticals Plans IPO of 21.9M Shares at $15-$17 Each - Yahoo Finance
ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie (Pending:ADRX) - Seeking Alpha
ADARx Pharmaceuticals, Inc. Common Stock Stock (ADRX) Financials Data
There is no financial data for ADARx Pharmaceuticals, Inc. Common Stock (ADRX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
ADARx Pharmaceuticals, Inc. Common Stock Stock (ADRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| George Simeon | Director |
Sep 28 '26 |
Buy |
17.00 |
1,600,000 |
27,200,000 |
5,554,094 |
| GORDON CARL L | Director |
Sep 28 '26 |
Buy |
17.00 |
950,000 |
16,150,000 |
14,325,529 |
| ORBIMED ADVISORS LLC | Director |
Sep 28 '26 |
Buy |
17.00 |
950,000 |
16,150,000 |
14,325,529 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
Sep 28 '26 |
Buy |
17.00 |
1,600,000 |
27,200,000 |
5,554,094 |
1.20%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):